Lv3
400 积分 2023-12-22 加入
Long-Residence Time Peptide Antagonist for the Vasopressin V2 Receptor to Treat Autosomal Dominant Polycystic Kidney Disease
2天前
已完结
Structural basis of tolvaptan binding to the vasopressin V2 receptor
2天前
已完结
The protection impact of tectoridin on PC12 cell preventing OGD/R-caused damage through PI3K/AKT signaling channel
11天前
已完结
MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes
1个月前
已完结
MET alterations in NSCLC—Current Perspectives and Future Challenges
1个月前
已完结
[Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer]
1个月前
已完结
Proximal tubule LPA1 and LPA2 receptors use divergent signaling pathways to additively increase profibrotic cytokine secretion
1个月前
已关闭
Identification of novel aminopyrimidine derivatives for the treatment of mutant NSCLC
1个月前
已完结
Tackling Osimertinib Resistance in EGFR-Mutant Non–Small Cell Lung Cancer
2个月前
已完结
Acquired resistance mechanisms to osimertinib: The constant battle
2个月前
已完结
皖公网安备34019202002308
